This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

Covalent Drug Discovery Summit

97 97 people viewed this event.

Accelerating Screening and Discovery of Potent Covalent Inhibitors and Degraders with Improved Triaging, Selectivity and Safety for Targeting Hard-to-Drug Targets

 

Time: 7:30 AM – 5:00 PM

Venue Details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Drug Developer Pricing – Conference Only: USD 2999.00,
Drug Developer Pricing – Conference + 1 Workshop: USD 3648.00,
Drug Developer Pricing – Conference + 2 Workshops: USD 4297.00,
Academic Pricing – Conference Only: USD 2599.00,
Academic Pricing – Conference + 1 Workshop: USD 3148.00,
Academic Pricing – Conference + 2 Workshops: USD 3697.00,
Solution Provider Pricing – Conference Only: USD 3799.00,
Solution Provider Pricing – Conference + 1 Workshop: USD 4548.00,
Solution Provider Pricing – Conference + 2 Workshops: USD 5297.00

Speakers: Alun Bermingham, Senior Vice President and Head of Platform, Totus Medicines, Anthony Rullo, Associate Professor of Medicine and Chemical Biology, McMaster University, Brent Martin, Vice President – Head of Chemical Biology, Scorpion Therapeutics, Brian Lanman, Director of Research, Amgen, and more

Event Organizer - Hanson Wade

 

Date

12–14 December 2023
 

City

 

Country

 

Topic Area

Share With Colleagues